Ziconotide: Neuronal Calcium Channel Blocker for Treating Severe Chronic Pain
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
3029-3040
Author(s):
G. P. Miljanich
Magnesium as a Neuroprotective Agent in Cerebral Ischemia
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
4
Page:
215-222
Author(s):
C.C. Ionita, J.F. Kirmani, A.R. Xavier and A.I. Qureshi
α-Fibrinogenases
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
4
Page:
417-435
Author(s):
S. Swenson, C. F. Toombs, L. Pena, J. Johansson and F. S. Markland Jr.
Propofol: Therapeutic Indications and Side-Effects
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3639-3649
Author(s):
Paul E. Marik
Involvement of the Endogenous Opioid System in Cannabinoid Responses
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
4
Page:
183-193
Author(s):
Olga Valverde, Patricia Robledo and Rafael Maldonado
Molecular and Cellular Mechanisms in the Pathophysiology of Severe Head Injury
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2131-2143
Author(s):
Enriquez P and Bullock R.
Arterial Hyperoxia in Severe Head Injury: A Useful or Harmful Option?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2163-2176
Author(s):
O. L. Alves, W. P. Daugherty and M. Rios
Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2177-2183
Author(s):
Anat Biegon
Endothelins and the Role of Endothelin Antagonists in the Management of Posttraumatic Vasospasm
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2185-2192
Author(s):
W. M. Armstead
Moderate Hypothermia in the Management of Severe Traumatic Brain Injury: A Good Idea Proved Ineffective?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2193-2204
Author(s):
J. Sahuquillo, M. P. Mena, A. Vilalta and M. A. Poca